TIGIT marks exhausted T cells and serves as a target for immune restoration in patients with chronic HBV infection.

BACKGROUND Chronic HBV infection is a serious worldwide health problem that mainly causes liver cirrhosis and hepatocellular carcinoma (HCC). Few studies have explored how T cell exhaustion helps HBV avoid immune system attack and how to reverse that exhaustion. Recently, T cell immunoglobulin and immune receptor tyrosine-based inhibitory motif (ITIM) domain (TIGIT) have been identified as coinhibitory receptors, similar to PD-1. This study explores the expression of TIGIT and the T cell function changes in patients with chronic HBV infection. RESULTS In this study, we found that the expression of TIGIT on T cells increased significantly in patients with chronic HBV infection. High expression of TIGIT on T cells is associated with functional exhaustion. Importantly, this study demonstrates that blocking TIGIT can reverse T cell exhaustion and restore function in patients with chronic HBV infection. CONCLUSIONS HBV induces T cell exhaustion by up-regulating the expression of TIGIT. Blocking the TIGIT/PVR signaling pathway can reverse T cell exhaustion, so this discovery provides an immunotherapy target to battle chronic HBV infection.

[1]  C. Giaquinto,et al.  T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals , 2021, PLoS pathogens.

[2]  D. Hafler,et al.  TIGIT signaling restores suppressor function of Th1 Tregs. , 2019, JCI insight.

[3]  R. Sun,et al.  Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice , 2019, Nature Communications.

[4]  Lanjuan Li,et al.  Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update) , 2017, Journal of clinical and translational hepatology.

[5]  F. Hecht,et al.  Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8+ T Cell Exhaustion Marker Expression. , 2017, AIDS research and human retroviruses.

[6]  C. W. Kim,et al.  Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis , 2017, International journal of molecular sciences.

[7]  J. Leitner,et al.  PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells , 2017, Front. Immunol..

[8]  L. Taams,et al.  Inflammatory cytokines compromise programmed cell death‐1 (PD‐1)‐mediated T cell suppression in inflammatory arthritis through up‐regulation of soluble PD‐1 , 2017, Clinical and experimental immunology.

[9]  W. Chua,et al.  The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy. , 2016, Clinical colorectal cancer.

[10]  S. Lewin,et al.  CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART , 2016, PLoS pathogens.

[11]  Ana C Anderson,et al.  Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation. , 2016, Immunity.

[12]  J. Grogan,et al.  TIGIT Enhances Antigen-Specific Th2 Recall Responses and Allergic Disease , 2016, The Journal of Immunology.

[13]  H. Zarour.  Reversing T-cell Dysfunction and Exhaustion in Cancer , 2016, Clinical Cancer Research.

[14]  T. Schell,et al.  T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients , 2016, Clinical Cancer Research.

[15]  M. Ostrowski,et al.  TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection , 2016, PLoS pathogens.

[16]  A. Westfall,et al.  Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts , 2015, AIDS.

[17]  Paul A. Lyons,et al.  T cell exhaustion, costimulation and clinical outcome in autoimmunity and infection , 2015, Nature.

[18]  Joe-Marc Chauvin,et al.  TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients. , 2015, The Journal of clinical investigation.

[19]  X. Liu,et al.  T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance , 2015, Cell Death and Disease.

[20]  J. Hackney,et al.  The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. , 2014, Cancer cell.

[21]  R. Thimme,et al.  Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. , 2014, Journal of hepatology.

[22]  H. Pircher,et al.  Inhibitory Phenotype of HBV-Specific CD4+ T-Cells Is Characterized by High PD-1 Expression but Absent Coregulation of Multiple Inhibitory Molecules , 2014, PloS one.

[23]  C. Benoist,et al.  Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. , 2014, Immunity.

[24]  H. Nakasone,et al.  Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells. , 2014, Immunology letters.

[25]  J. Hong,et al.  In Vivo Blockade of the Programmed Cell Death-1 Pathway Using Soluble Recombinant PD-1-Fc Enhances CD4+ and CD8+ T Cell Responses but Has Limited Clinical Benefit , 2013, The Journal of Immunology.

[26]  K. Tamada,et al.  Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma , 2013, The Journal of Immunology.

[27]  L. Yao,et al.  Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8(+) T cell in HCC patients. , 2013, Immunology letters.

[28]  W. Rosenberg,et al.  Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection , 2012, PloS one.

[29]  I. Ushiro-Lumb,et al.  Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. , 2012, Gastroenterology.

[30]  Yanning Liu,et al.  Blockade of Tim‐3 signaling restores the virus‐specific CD8+ T‐cell response in patients with chronic hepatitis B , 2012, European journal of immunology.

[31]  I. Kang,et al.  Characterization of Effector Memory CD8+ T Cells in the Synovial Fluid of Rheumatoid Arthritis , 2012, Journal of Clinical Immunology.

[32]  E John Wherry,et al.  T cell exhaustion , 2011 .

[33]  T. Bukowski,et al.  Vstm3 is a member of the CD28 family and an important modulator of T‐cell function , 2011, European journal of immunology.

[34]  Vijay K. Kuchroo,et al.  Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions , 2011, The Journal of Immunology.

[35]  H. Pircher,et al.  Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma. , 2010, Cancer research.

[36]  Jenna M. Sullivan,et al.  Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity , 2010, The Journal of experimental medicine.

[37]  R. Ahmed,et al.  Features of responding T cells in cancer and chronic infection. , 2010, Current opinion in immunology.

[38]  N. Stanietsky,et al.  The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity , 2009, Proceedings of the National Academy of Sciences.

[39]  S. J. Griffiths,et al.  KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. , 2009, Blood.

[40]  B. Walker,et al.  PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention , 2009, The Journal of Immunology.

[41]  M. Colonna,et al.  A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC , 2009, European journal of immunology.

[42]  H. Clark,et al.  The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells , 2009, Nature Immunology.

[43]  G. Freeman,et al.  IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection , 2008, Proceedings of the National Academy of Sciences.

[44]  A. Bertoletti,et al.  Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection , 2007, Journal of Virology.

[45]  H. Yagita,et al.  Elimination of chronic viral infection by blocking CD27 signaling , 2006, The Journal of experimental medicine.

[46]  C. Blank,et al.  Negative regulation of T-cell function by PD-1. , 2004, Critical reviews in immunology.

[47]  D. Richman,et al.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.

[48]  M. Morimoto,et al.  The role of hepatitis B virus-specific memory CD8 T cells in the control of viral replication. , 2002, Journal of hepatology.